Bortoletto and Parchem explored the interplay between oncogenic Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations and miRNA regulatory pathways in ACC [122]. This evidence concerns the gene KRAS and adrenal cortex carcinoma.